New Delhi [India], May 27 (ANI): Pfizer on Wednesday said it continues to remain engaged with the Indian government towards making its coronavirus vaccine available for use in the government immunisation programme.
The decision to waive trials will only apply to the vaccines which have been approved for restricted use by US FDA and other countries or which are listed in WHO Emergency Use Listing (EUL).